TG Therapeutics, Inc. (TGTX) Misses Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts TGTX Hot Sheet
Join SI Premium – FREE
TG Therapeutics, Inc. (NASDAQ: TGTX) reported Q1 EPS of ($0.25), $0.06 worse than the analyst estimate of ($0.19).TG Therapeutics, Inc. reaffirmed FY2014 guidance.
For earnings history and earnings-related data on TG Therapeutics, Inc. (TGTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena beats estimates on strong AI-driven demand, shares rise
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
